Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways

Journal of Steroid Biochemistry and Molecular Biology

Volumn 83, Issue 1-5, 2002, Pages 173-186

  Edwards, Dean P ^a   Wardell, Suzanne E ^a   Boonyaratanakornkit, Viroj ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

DNA binding domains (DBD); Jun dimerization protein 1 (JDP 1); Ligand binding domains (LBD); Progesterone receptor; Src tyrosine kinase

Indexed keywords

ANTIGESTAGEN; JUN DIMERIZATION PROTEIN 2; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN KINASE P60; PROTEIN P160; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUN; UNCLASSIFIED DRUG; HCK PROTEIN, HUMAN; HEMATOPOIETIC CELL KINASE; IFNGR2 PROTEIN, HUMAN; INTERFERON RECEPTOR; JDP2 PROTEIN, HUMAN; LIGAND; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; REPRESSOR PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CROSS LINKING; DNA BINDING; DNA BINDING MOTIF; DRUG ACTIVITY; DRUG POTENTIATION; ENDOMETRIUM; GENETIC ANALYSIS; HORMONE BINDING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REPORTER GENE; SCREENING; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TWO HYBRID SYSTEM; YEAST; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL STRAIN COS1; CHEMISTRY; CHROMATIN; DOSE RESPONSE; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CHROMATIN; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENES, REPORTER; HUMANS; LIGANDS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; RECEPTORS, INTERFERON; RECEPTORS, PROGESTERONE; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0038657687     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00265-0     Document Type: Conference Paper

References (49)

1. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141.
2. Edwards D.P. Coregulatory proteins in nuclear receptor action. Vitam. Horm. 55:1999;165-218.
3. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 108:2002;465-474.
4. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:1998;2008-2018.
5. Boonyaratanakornkit V.M., Scott M., Ribon V., Sherman L., Anderson S., Maller J., Miller W., Edwards D. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell. 8:2001;269-280.
6. Ferrell J.E. Xenopus oocyte maturation: new lessons from a good egg. Bio. Essays. 21:1999;833-842.
7. Cheung J., Smith D.F. Molecular chaperone interactions with steroid receptors: an update. Mol. Endocrinol. 14:2000;939-946.
8. Tsai M.-J., O'Malley B. Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
9. Bourguet W., Germain P., Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. TIPS. 21:2000;381-388.
10. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., Horwitz K.B. The N-terminal region of the human progesterone A-receptor. J. Biol. Chem. 275:2000;7313-7320.
11. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., Horwitz K.B. The N-terminal region of human progesterone N-receptors. J. Biol. Chem. 276:2001;23825-23831.
12. Feng W., Ribeiro R., Wagner R., Nguyen H., Apriletti J., Fletterick R., Baxter J., Kushner P., West B. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280:1998;1747-1749.
13. Ma H., Hong H., Huang S.-M., Irvine R., Webb P., Kushner P., Coetzee G., Stallcup M. Multiple signal input and output domains of the 160 kDa nuclear receptor coactivator proteins. Mol. Cell. Biol. 19:1999;6164-6173.
14. Meyer M.-E., Quirin-Stricker C., Lerouge T., Bocquel M.-T., Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267:1992;10882-10887.
15. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13:1999;910-924.
16. Shiau A., Barstad D., Loria P., Cheng L., Kushner P., Agard D., Greene G. The structural basis of estrogen receptor/coactivator recognition and the antagonist of this alteration by tamoxifen. Cell. 7:1999;927-937.
17. Meyer M.-E., Pornon A., Ji J., Bocquel M.-T., Chambon P., Gronemeyer H. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 9:1990;3923-3932.
18. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1990;1603-1614.
19. Giangrande P.H., McDonnell D.P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Rec. Prog. Horm. Res. 54:1999;291-313.
20. Conneely O.M., Lydon J.P. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids. 65:2000;571-577.
21. Conneely O.M., Mulac-Jericevic B., Lydon J.P., DeMayo F.J. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol. Cell. Endocrinol. 179:2001;97-103.
22. Aronheim A., Zandi E., Hennemann H., Elledge S., Karin M. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 17:1997;3094-3102.
23. SNFT protein. J. Immunol. 165:2000;860-868.
24. Jin C., Ugai H., Song J., Murata T., Nili F., Sun K., Horikoshi M., Yokoyama K. Identification of mouse Jun dimerization protein-2 as a novel repressor of ATF-2. FEBS Lett. 489:2001;31-41.
25. Baudino T., Kraichely D., Jefcoat S. Jr., Winchester S., Partridge N., MacDonald P. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J. Biol. Chem. 273:1998;16434-16441.
26. Zhou S., Fujimuro M., Hsieh J.-D., Chen L., Miyamoto A., Weinmaster G., Hayward S. SKIP, a CBF-associated protein, interacts with the ankyrin repeat domain of NotchIC to facilitate NotchIC function. Mol. Cell. Biol. 20:2000;2400-2410.
27. Zhou S., Fujimuro M., Hsieh J.J.-D., Chen L., Hayward S.D. A role for SKIP in EBNA2 activation of CBF1-repressed promoters. J. Virol. 74:2000;1939-1947.
28. Tsuchimoto D., Sakai Y., Sakumi K., Nishioka K., Sasaki M., Fujiwara T., Nakabeppu Y. Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen. Nucl. Acids Res. 29:2001;2349-2360.
29. Jayaraman L., Murthy K.G.K., Zhu C., Curran T., Xanthoudakis S., Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:1997;558-570.
30. Ribon V., Printen J.A., Hoffman N.G., Kay B.K., Saltiel A.R. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3% 3-L1 adipocytes. Mol. Cell. Biol. 18:1998;872-879.
31. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., Bickel P.E., Pessin J.E., Saltiel A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature. 407:2000;202-207.
32. Ribon V., Herrera R., Kay B.K., Saltiel A.R. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J. Biol. Chem. 273:1998;4073-4080.
33. Piu F., Aronheim A., Katz S., Karin M. AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation. Mol. Cell. Biol. 21:2001;3012-3024.
34. Wardell S.E., Boonyaratanakornkit V., Adelman J.S., Aronheim A., Edwards D.P. Jun dimerization protein-2 (JDP-2) functions as a progesterone receptor N-terminal domain coactivator. Mol. Cell. Biol. 22:2002;5451-5466.
35. Nordeen S., Kuhnel B., Lawler-Heavner J., Barber D., Edwards D. Quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol. Endocrinol. 3:1989;1270-1278.
36. Onãte S., Boonyaratanakornkit V., Spencer T., Tsai S., Tsai M.-J., Edwards D., O'Malley B. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF-1) and AF-2 domains of steroid receptors. J. Biol. Chem. 273:1998;12101-12108.
37. Boruk M., Savory J., Hache R. AF-2-dependent potentiation of CCAAT enhancer binding protein β-mediated transcriptional activation by glucocorticoid receptor. Mol. Endocrinol. 12:1998;1749-1763.
38. Christian M., Pohnke Y., Kempf R., Gellersen B., Brosens J. Functional association of PR and CCAAT/enhancer-binding protein β isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol. Endocrinol. 16:2002;141-154.
39. Schwarz E., Reginato M., Shao D., Krakow S., Lazar M. Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol. Cell. Biol. 17:1997;1552-1561.
40. Stein B., Yang M. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kB and C/EBPβ Mol. Cell. Biol. 15:1995;4971-4979.
41. Brown M.T., Cooper J.A. Regulation, substrates and functions of SRC (review). Biochim. Biophys. Acta. 1287:1996;121-149.
42. Thomas S.N., Brugge J.S. Cellular functions regulated by SRC family kinases. Ann. Rev. Cell Dev. Biol. 13:1997;513-609.
43. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., Kuriyan J. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell. 3:1999;639-648.
44. Xu W., Doshi A., Lei M., Eck M.J., Harrison S.C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell. 3:1999;629-638.
45. Moarefi I., Lafevre-Bernt M., Sicheri F., Huse M., Lee C.-H., Kuriyan J., Miller W.T. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:1997;650-653.
46. Sutherland R.L., Prall O.W.J., Watts C.K.W., Musgrove E.A. Estrogen and progestin regulation of cell cycle progression. J. Mammary Gland Biol. Neoplasia. 3:1998;63-72.
47. J. Lambert, S. Nordeen, Analysis of steroid hormone-induced acetylation by chromatin immunoprecipitation assay, in: B. Lieberman (Ed.), Methods in Molecular Biology, vol. 176, Humana Press Inc., Totowa, NJ, 2001, pp. 273-281.
48. 416. J. Biol. Chem. 275:2000;2721-2726.
49. Hunter S., Burton E., Wu S., Anderson S. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphotidylinositol 3-kinase. J. Biol. Chem. 274:1998;2097-2106.